Zobrazeno 1 - 10
of 27
pro vyhledávání: '"S. Herzog-Hauff"'
Autor:
Dieter Glebe, S. Grün, D. Strand, I. Mederacke, Soheila Tavakoli, W. O. Böcher, Adam J. Gehring, Stephan Urban, Peter R. Galle, S. Herzog-Hauff
Publikováno v:
Clinical and Experimental Immunology. 151:61-70
Summary Persistence of hepatitis B virus (HBV) infection is associated with reduced anti-viral T cell responses. Impaired dendritic cell (DC) function was suggested as the cause of reduced T cell stimulation in chronic HBV carriers. Thus, we compared
Publikováno v:
Journal of Medical Virology. 66:452-460
To evaluate therapeutic immunostimulation nine chronic hepatitis B patients received six monthly intradermal vaccinations with HBsAg in combination with daily lamivudine. Another five patients received six doses of the vaccine and daily lamivudine to
Publikováno v:
Hepatology. 31:521-527
The vaccination route may influence the success of immunization against pathogens. The conventional intramuscular (i.m.) application of a vaccine containing the hepatitis B virus (HBV) surface antigen (HBsAg) led to protective anti-HBs antibody level
Autor:
S. Herzog-Hauff, W. O. Böcher, Karl-Hermann Meyer zum Büschenfelde, Hanns Friedrich Löhr, Jörg F. Schlaak
Publikováno v:
Hepatology. 29:238-244
Because cellular and humoral immune responses against the hepatitis B virus (HBV) surface antigen (HBs) might be crucial to overcome HBV infection, HBs-specific B- and T-cell responses of HBV patients and HBs vaccine recipients were analyzed quantita
Autor:
S. Herzog-Hauff, G. Gerken, K H Meyer zum Büschenfelde, W. O. Böcher, Hanns F. Löhr, K. H. Heermann, Wolfgang Herr
Publikováno v:
Clinical and Experimental Immunology. 105:52-58
Antibodies directed to the HBs antigen indicate viral clearance and the development of life-long immunity in patients that recovered from HBV infection. In HBs antigen vaccine recipients anti-HBs antibodies provide protective immunity. However, littl
Publikováno v:
Zeitschrift für Gastroenterologie. 45
Publikováno v:
Zeitschrift für Gastroenterologie. 45
Introduction: The strength and breadth of antiviral T cell response is correlated with disease outcome from hepatitis B. Thus, induction of HBV-specific T cells by therapeutic vaccination might represent a new therapeutic strategy, as demonstrated in
Publikováno v:
Hepatology (Baltimore, Md.). 31(2)
The vaccination route may influence the success of immunization against pathogens. The conventional intramuscular (i.m.) application of a vaccine containing the hepatitis B virus (HBV) surface antigen (HBsAg) led to protective anti-HBs antibody level
Publikováno v:
Hepatology (Baltimore, Md.). 29(1)
Because cellular and humoral immune responses against the hepatitis B virus (HBV) surface antigen (HBs) might be crucial to overcome HBV infection, HBs-specific B- and T-cell responses of HBV patients and HBs vaccine recipients were analyzed quantita
Publikováno v:
Journal of molecular medicine (Berlin, Germany). 75(9)
Analysis of the variable chains (V alpha/V beta) of the specific T cell receptor (TCR) of organ-infiltrating T cells may provide further insights into the pathogenesis of many infectious diseases, malignancies, and autoimmune disorders. To determine